Proteomics International Laboratories Health Care
Biotech Cancer Healthcare Medical New Zealand North America Western Australia

$0.860 0.010 (1.18%)

High $0.88	Low $0.86	Trades 19	Turnover $55,369	Volume 64,140
30 June 2023 at 3:08pm

Market Cap (2-Oct) $21,498,504 (840th)	Close (30-Jun) $0.86 0 (0%)	Volume (30-Jun) 64,140	Shortsold (28-Sep) 799,744 (0.48%) (332nd)
52w High $0.86	52w Low $0.098	P/E -	EPS -0.05

Short Interest

ASIC data, 28 Sep 2026

% Shorted

0.48% 0.02

vs 0.50% prior report

Most Shorted Rank

332nd

of 704 shorted ASX stocks

Peak Short

0.71%

Aug 2026

Days to Cover

7.7

at 50d avg vol

View full short position history →

	Subject
	PIQ PIQ Ann: Proposed issue of Securities - PIQ
	1 (current) 2 3
	PIQ PIQ Ann: Issue of Options and Secondary Trading Notice
	PIQ PIQ Ann: March 2021 Quarterly Activities Report and Appendix 4C
	PIQ PIQ Ann: Proteomics files US FDA 513(g) regulatory submission
	PIQ PIQ Ann: ISO 13485 certification received - Manufacturing Update
	PIQ PIQ Ann: Exercise of Options
	PIQ PIQ Ann: Investor Presentation
	PIQ PIQ Ann: Exercise of Options
	PIQ PIQ Ann: Appendix 4D and Interim Financial Report
	PIQ PIQ Ann: Response to Price Query
	PIQ PIQ Ann: Proteomics International seeks FDA approval for PromarkerD
	PIQ PIQ Ann: Update - Proposed issue of Securities - PIQ
	PIQ PIQ Ann: Issue of Options and Secondary Trading Notice
	PIQ PIQ Ann: Results of Meeting
	PIQ PIQ Ann: December 2020 Quarterly Activities Report and Appendix 4C
	PIQ PIQ Ann: Notice of Extraordinary General Meeting/Proxy Form
	PIQ PIQ Ann: Results of Meeting
	PIQ PIQ Ann: AGM Investor Presentation
	PIQ PIQ Ann: Middle East is next market for PromarkerD immunoassay test
	PIQ PIQ Ann: PromarkerD clinical assay performance results published
	PIQ PIQ Ann: Change in substantial holding - Dunlop
	PIQ PIQ Ann: Change in substantial holding - Lipscombe
	PIQ PIQ Ann: Proteomics receives $1.1 million in R&D tax incentive
	PIQ PIQ Ann: Completion of Placement and Appendix 2A
	PIQ PIQ Ann: September 2020 Quarterly Activities Report and Appendix 4C
	PIQ PIQ Ann: Notice of Annual General Meeting/Proxy Form
	PIQ PIQ Ann: Proteomics International raises $6m in successful Placement
	PIQ PIQ Ann: Proposed issue of Securities - PIQ
	PIQ PIQ Ann: Proposed issue of Securities - PIQ
	PIQ PIQ Ann: Trading Halt
	PIQ PIQ Ann: First distribution agreement for PromarkerD immunoassay

Similar Companies

AnteoTech

ADO

BPH Energy

BPH

Cryosite

CTE

Genetic Signatures

GSS

Genetic Technologies

GTG

Memphasys

MEM

OncoSil Medical

OSL

Palla Pharma

PAL

End of Day Prices

Date	Close	Volume	Change
02-Oct	$0.12	106,199	-0.01 (7.69%)
01-Oct	$0.13	26,006	-0.01 (3.70%)
30-Sep	$0.14	25,107	+0.01 (8.00%)
29-Sep	$0.13	57,840	0.00 (0.00%)
28-Sep	$0.13	45,973	+0.01 (8.70%)
25-Sep	$0.12	164,668	0.00 (4.17%)
24-Sep	$0.12	79,547	+0.00 (4.35%)
23-Sep	$0.12	425,010	-0.02 (14.81%)
22-Sep	$0.14	33,541	0.00 (0.00%)
21-Sep	$0.14	11,213	+0.01 (3.85%)
18-Sep	$0.13	169,158	-0.01 (7.14%)
17-Sep	$0.14	89,709	0.00 (0.00%)
16-Sep	$0.14	31,909	+0.01 (3.70%)
15-Sep	$0.14	82,277	-0.01 (3.57%)
14-Sep	$0.14	113,363	0.00 (0.00%)
5 up, 6 down, and 4 flat days

Proteomics International Laboratories Health Care
Biotech Cancer Healthcare Medical New Zealand North America Western Australia

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Proteomics International Laboratories Health Care Biotech Cancer Healthcare Medical New Zealand North America Western Australia

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Proteomics International Laboratories Health Care
Biotech Cancer Healthcare Medical New Zealand North America Western Australia